Está en la página 1de 2

c cc

c
c c
c  c   

 cccc c 

c  c

 | | | 
  | |  | | | | |
|  | |  | | |
| |  |   |  |

 
| | |
  | ||  |
 
| |

 |  |   | | |  | 


| |  |


 |
||
  | | ||drug resistant TB || |
! |  | "##$"#%#|  | 
| &'|  |  | |  | |
 || |
|
| |  | |
   |  |  |
 |  |  |    |  |
|| | || |! | |"##$"#%#||
 !| |(| | | |
 )  | || *| |
 |  |  | |  | || | |||

||
 || || !|| || |! | |"##$
"#%#| + |  |  | |  | | |   | | 
  |
,-./| |  | "##$"#%#|   |  |  |  |  |  | |  | |
 | | | 0
| 1| 
  | |  |   |  |
 | |  | | |  | | | 0
| 1| 
  |
! |
 | ||* |non random sampling  |Purposive sampling|
|
 | | |%##|
| ||  | |%| |2|
"#| | / |  |   |
3| | | !0| 04%5'6| |  |
 |
| 047'|  | 3| 
| 0452"$|  | |   |
|  || |04%"#2| | |  ||| | |
|   | 
| 04%#|
|  |  |  | | |
 | |
 |  | |  |  | 
 | | | !0|
| ||  | | |
 || || ||
 || |* | |3 | |
|||
|
| |   | º eºlist|  |
|
| !0| + |  |  | |
|  |  | |  !|  |  |   | *| |
| || || | |  | | *| ||
 || || |
$#% &#&!#"#""#









÷ 
       ÷      
 


|
c  c'
÷ : Tuberºulosis (TB) is an infeºtious disease t at remains a signifiºant publiº
ealt problem, bot in Indonesia and ot er developing ºountries. Combating
tuberºulosis, espeºially in developing ºountries is still not satisfaºtory. T e problem faºed
is t e emergenºe of resistanºe to several anti-tuberºulosis drugs or nown drug resistant
TB (DR-TB). In t e ºity of Maassar in 2009-2010, t ere were as many as 65 ºases of
pulmonary tuberºulosis patients w o experienºed inºidents of drug resistanºe.
 !"#$%"& : T is study aims to determine t e ris of be avioral faºtors on t e inºidenºe of
resistant pulmonary tuberºulosis in Maassar 2009-2010.
"#'& : T is researº is observational analytiº study using ºase ºontrol study design.
T e population is all pulmonary tuberºulosis patients w o ºame and went to ealt
serviºes ( ospitals, BBKPM and PHC) in Maassar 2009-2010. T e sample is t e sputum
of pulmonary tuberºulosis patients t at were ºultured in t e laboratory NECHRI in t e
year 2009-2010 w iº ºonsists sample ºases of pulmonary TB patients w o experienºed
events of antituberºulosis drug resistant w ile a ºontrol sample of pulmonary TB patients
w o do not experienºe events of antituberºulosis drug Resistant. Sampling met ods by
non-random sampling, namely purposive sampling wit t e number of sample 100
ºomparison ºases and ºontrols was 1: 4.
"&(# : T e results s owed t at t ere was no Drug Taing Observer (DTO) (OR=1.758),
not taing mediºation ad erenºe (OR=3.5), as a istory of treatment (OR=7.429), and
still smoing sinºe diagnosis pulmonary TB (OR=1.204), are t e ris faºtors of t e
inºidenºe of pulmonary tuberºulosis resistant w ile treatment disorder (OR=1.0) is not a
ris faºtor for inºidenºe of resistant pulmonary tuberºulosis.
"&#$ : T is study suggests t e need to provide DTO for understanding of t e tass
and information t at s ould be given to patients wit pulmonary tuberºulosis, w o
experienºed t e event of resistanºe, t e inºlusion of ºyºle sº edule of drug taing on t e
paºaging of drugs and provides a º eºlist ºard for t e DTO. Also expeºted for t e
related institutions ( ospitals, BBKPM, ealt ºenters) to perform a ºomplete listing of
data related to pulmonary tuberºulosis patients w o experienºed inºidents of resistanºe in
order to faºilitate t e traºing.||
")*& :  "(&$&+÷"'%$+$"#&,"&$&#"